Company intelligence / Profile preview

Tower Capital Group

New York, New York, USA

Ownership: Private
Development stage: Other

Overview

Tower Capital Group pioneers the category of “Generational Health,” investing over $20B in assets globally to define and accelerate health-related economic and scientific progress; it curates and supports a cohort of health innovation companies.

Industry: Investors

Partnerships

World Economic Forum (WEF)United Nations Population Fund (collaboration via key executive)HekaBio K.K. (for expansion in Japan/Asia)

Beyond the preview

Go deeper on Tower Capital Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tower Capital Group.

Explore the full profile